EDN1 and Myocardial fibrosis: Additionally, alterations in cardiac metabolism, such as glucose-independent pathways such as adipokines, endothelin-1 (ET-1) shifting towards the use of fatty acids for energy production, and neurohumoral pathways, can also activate cardiac fibroblasts, contributing to the development of pathologic myocardial fibrosis [15].